Michael Hufford

Entrepreneur, drug developer, researcher, carpenter and guitar player, in decreasing order of talent (with a serious drop-off after #3)

[Michael Hufford @MichaelHufford]

@PeterDiamandis It is changing Peter, today, but eliminating organ wait lists all together will take more time than any of us would like... https://t.co/p1BL8dCd6N

[President Biden Archived @POTUS46Archive]

Today, the FDA approved another over the counter naloxone nasal spray product – a medicine that reverses opioid overdoses and saves lives.

Beating the opioid and overdose epidemic is a core pillar of my Unity Agenda. My Administration has committed unprecedented resources to crackdown on drug trafficking and expand access to addiction treatment, prevention, and recovery support services.

[Michael Hufford @MichaelHufford]

@POTUS Thanks Mr. President, we developed RiVive through our nonprofit pharma company @HRTherapeutics to reduce the price of life-saving naloxone https://t.co/43OHAcHK6O

[NPR Health News @NPRHealth]

Over-the-counter Narcan will save lives, experts say. But the cost will affect access https://t.co/IdeEyiVYmc

[Morphoceuticals @morphoceuticals]

Morphoceuticals is pleased to announce our seed funding for our programs using electroceuticals in limb regeneration and amputation stump health.
https://t.co/lQnfYOIMFt

[LyGenesis @LyGenesis_Inc]

Many cell therapy approaches require genetic engineering that reprograms cells to fight a specific disease. Conversely, our allogeneic cell therapy platform does not involve genetic engineering, simplifying the regulatory and commercial pathway.

#CellTherapy

[HR Therapeutics @HRTherapeutics]

OTC nalxone is one step closer... @Surgeon_General @DrCaliff_FDA @POTUS @ScottGottliebMD @ZachWritesStuff @maiasz @nabarund https://t.co/vPQisuNHkA

[LyGenesis @LyGenesis_Inc]

We are developing a pipeline of allogeneic cell therapies. Our platform leverages the lymph node as an in vivo bioreactor to grow functioning ectopic organs.
#LymphNode #DrugDiscovery #Type1Diabetes #TissueRegeneration #OrganRegeneration #RegenerativeMedicine #cell #Allogeneic

[Michael Hufford @MichaelHufford]

A review of our recent progress using our cell therapy platform @LyGenesis_Inc to regenerate organs... https://t.co/RIGigEN1W4

[Michael Hufford @MichaelHufford]

@ZachWritesStuff, as compelling and moving as ever... Guernica: Naloxone https://t.co/vFhYlvFJU4 via @GuernicaMag

[Michael Hufford @MichaelHufford]

@wonderofscience Incredible!

[HR Therapeutics @HRTherapeutics]

Harm Reduction Therapeutics' Phase 1 clinical trial met its primary endpoints -- this successful milestone triggers work on a new drug application of a low cost, over-the-counter (OTC) intranasal naloxone product for FDA to review https://t.co/o9K9fuRSmX

[LyGenesis @LyGenesis_Inc]

Prometheus Unbound: From Myth to the Clinical Reality of Organ Regeneration. Check out CEO, Michael Hufford's, talk at this years Investing in the Age of Longevity Conference

https://t.co/CWUNtK9nyG

[Master Investor @masterinvestor]

Next we’re joined by @michaelhufford, CEO and co-founder of #LeGenesis as he discusses ‘Prometheus Unbound: From Myth to the Clinical Reality of Organ Regeneration’. #MILongevity #LongevityWeek

[Longevity Technology @LongevityTech]

LyGenesis adds inborn #metabolism errors to drug pipeline...
#LyGenesis adds orphan paediatric indications to its drug development pipeline with novel approach for treating patients with Maple syrup urine disease.
#longevity #MSUD @MichaelHufford #liver
https://t.co/DIba1lqvT5

[Michael Hufford @MichaelHufford]

@profgalloway No, we've HAD a crisis... for years. We've also had life saving naloxone since 1971, but lack of access & price gouging by many manufacturers -- looking at you @emergentbiosolu -- means hundreds of Americans continue to die each day. We need OTC naloxone now

[HealthcareNOWradio @HCNowRadio]

This week on #TheIncrementalist Grow Your Own Organs, with @MichaelHufford, CEO Lygenesis; discussion includes using the bodies own bio-reactor (lymph nodes) to grow replacement liver, recent FDA clearance to proceed to human trials, and more https://t.co/eUCUAjgpLU

[Michael Hufford @MichaelHufford]

An important and thoughtful take on the tragic implications of our collective inability to reign in the costs of life-saving naloxone... https://t.co/noTJVfq5tT

[Longevity Leaders @longevityleader]

What have we learned from setbacks and how to move the field forward post-COVID
Hear from @MichaelHufford Maddalena Adorno Dorian Therapeutics Natalia Novac @LillyPad
Wed 5th May 1600 BST
Register for free
https://t.co/N4PCP2jIDz
Part of the #Longevity Leaders Congress
#ageing

[Michael Hufford @MichaelHufford]

LyGenesis in the news... https://t.co/zccmQQlHy4